These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 24943297)

  • 21. [Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone].
    Simkó J; Barta K; Szabó Z; Varga E; Nagy E; Lorincz I
    Orv Hetil; 2004 Nov; 145(48):2411-7. PubMed ID: 15638034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
    Celani MF; Bonati ME; Stucci N
    Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular risk with subclinical hyperthyroidism and hypothyroidism: pathophysiology and management.
    Duggal J; Singh S; Barsano CP; Arora R
    J Cardiometab Syndr; 2007; 2(3):198-206. PubMed ID: 17786084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Subclinical thyroid disease].
    Nakajima Y; Yamada M
    Nihon Rinsho; 2012 Nov; 70(11):1865-71. PubMed ID: 23214054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study.
    Rodondi N; Bauer DC; Cappola AR; Cornuz J; Robbins J; Fried LP; Ladenson PW; Vittinghoff E; Gottdiener JS; Newman AB
    J Am Coll Cardiol; 2008 Sep; 52(14):1152-9. PubMed ID: 18804743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thyroid hormones and cardiovascular system].
    Límanová Z; Jiskra J
    Vnitr Lek; 2016; 62(9 Suppl 3):92-98. PubMed ID: 27734699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subclinical hyperthyroidism.
    Koutras DA
    Thyroid; 1999 Mar; 9(3):311-5. PubMed ID: 10211610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of subclinical thyroid dysfunction in heart failure.
    Frey A; Kroiss M; Berliner D; Seifert M; Allolio B; Güder G; Ertl G; Angermann CE; Störk S; Fassnacht M
    Int J Cardiol; 2013 Sep; 168(1):300-5. PubMed ID: 23041000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The influence of subclinical thyroid dysfunction on cardiac hemodynamic and electrophysiological parameters in patients with coronary heart disease and paroxysmal atrial fibrillation].
    Rakhmatullov FK; Klimova SV; Rudakova LE; Pchelinsteva SA; Rakhmatullov AF; Khodakova AI
    Klin Med (Mosk); 2012; 90(10):31-4. PubMed ID: 23285759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Subclinical thyroid disorders].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2006 Dec; 21(126):573-8. PubMed ID: 17405301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial fibrillation associated with subclinical hyperthyroidism.
    Patanè S; Marte F
    Int J Cardiol; 2009 May; 134(3):e155-8. PubMed ID: 19185365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence and prognostic effects of subclinical thyroid dysfunction in dilated cardiomyopathy patients: a single-center cohort study.
    Li X; Yang X; Wang Y; Ding L; Wang J; Hua W
    J Card Fail; 2014 Jul; 20(7):506-12. PubMed ID: 24858054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Subclinical hyperthyroidism].
    Feldkamp J
    Dtsch Med Wochenschr; 2013 Oct; 138(42):2146-50. PubMed ID: 23873176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk.
    Nanchen D; Gussekloo J; Westendorp RG; Stott DJ; Jukema JW; Trompet S; Ford I; Welsh P; Sattar N; Macfarlane PW; Mooijaart SP; Rodondi N; de Craen AJ;
    J Clin Endocrinol Metab; 2012 Mar; 97(3):852-61. PubMed ID: 22238391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial fibrillation and acute myocardial infarction without significant coronary stenoses associated with subclinical hyperthyroidism and erythrocytosis.
    Patanè S; Marte F
    Int J Cardiol; 2010 Nov; 145(1):e36-9. PubMed ID: 19185939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function].
    Biondi B; Fazio S; Palmieri EA; Tremalaterra R; Angellotti G; Bonè F; Riccio G; Cittadini A; Lombardi G; Saccà L
    Cardiologia; 1999 May; 44(5):443-9. PubMed ID: 10389349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation between thyroid-stimulating hormone and the occurrence of cardiovascular events and mortality in patients with manifest vascular diseases.
    Westerink J; van der Graaf Y; Faber DR; Spiering W; Visseren FL;
    Eur J Prev Cardiol; 2012 Aug; 19(4):864-73. PubMed ID: 21724680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid function and the risk of coronary heart disease: 12-year follow-up of the HUNT study in Norway.
    Asvold BO; Bjøro T; Platou C; Vatten LJ
    Clin Endocrinol (Oxf); 2012 Dec; 77(6):911-7. PubMed ID: 22724581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subclinical hypothyroidism and cardiovascular risk: recommendations for treatment.
    Weiss IA; Bloomgarden N; Frishman WH
    Cardiol Rev; 2011; 19(6):291-9. PubMed ID: 21983317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid Dysfunction and Cardiovascular Events in Patients With Dysglycemia.
    Shah R; Orlov S; Paré G; Gerstein HC;
    Can J Diabetes; 2023 Apr; 47(3):257-262. PubMed ID: 36858924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.